C22orf13 antibody (AA 51-150) (Biotin)

Catalog No. ABIN1700921

The Rabbit Polyclonal anti-C22orf13 antibody has been validated for WB, ELISA, IHC (fro) and IHC (p). It is suitable to detect C22orf13 in samples from Human.

Quick Overview for C22orf13 antibody (AA 51-150) (Biotin) (ABIN1700921)

Target: C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This C22orf13 antibody is conjugated to Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Product Details anti-C22orf13 Antibody (Biotin)

Binding Specificity: AA 51-150

Cross-Reactivity: Human

Predicted Reactivity: Mouse,Rat,Dog,Horse

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C22orf13

Isotype: IgG

Application Details

Application Notes: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for C22orf13

Target: C22orf13 (GUCD1) (Guanylyl Cyclase Domain Containing 1 (GUCD1))

Alternative Name: C22orf13

Background:

Synonyms: C22orf13, CG13760 gene product [Drosophila melanogaster] homolog, Chromosome 22 open reading frame 13, CV013_HUMAN, LLN4, MGC1842, OTTHUMP00000198388, Protein LLN4, Uncharacterized protein C22orf13.

Background: Chromosome 22 contains over 500 genes and about 49 million bases. Being the second smallest human chromosome, 22 contains a surprising variety of interesting genes. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia. The C22orf13 gene product has been provisionally designated C22orf13 pending further characterization.

Gene ID: 83606